IP Library Assignment 014269/0426
Patent Assignment
Reel/Frame 014269/0426

Security Agreement

Recorded: 2004-01-20 Pages: 12
Assignor
Assignee
ENANTA PHARMACEUTICALS, INC.
750 MAIN STREET, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties (45)
9-Amino-14-Membered Macrolide Devived from Leucomycin
Bicyclic Leucomycins
Cyclosporins for the Treatment of Respiratory Diseases
4-Substituted Leucomycins
Cyclosporin Analogs for the Treatment of Autoimmune Diseases
Cyclosporin Anlogs for Treatment of Lung Diseases
Methods and Compositions for Identifying Peptide Aptamers Capable of Altering a Cell Phenotype
Cyclosporins for the Treatment of Respiratory Diseases
Patent: 6,784,156 →
Application: 09/800,856 →
Publication: US 2002/0142946
4' -Substituted Leucomycins
Patent: 6,680,299 →
Application: 09/917,107 →
Publication: US 2003/0096763
Synthesis of Compounds and Libraries of Compounds
Patent: 7,183,059 →
Application: 09/949,280 →
Publication: US 2002/0016010
Cyclosporin analogs for the treatment of lung diseases
Application: 09/975,923 →
Publication: US 2003/0087813
Cyclosporin Analogs for the Treatment of Autoimmune Diseases
Patent: 6,809,077 →
Application: 09/976,219 →
Publication: US 2003/0104992
Novel Tylosin Derivatives Having Antibacterial Activity
Patent: 6,664,240 →
Application: 10/002,918 →
Publication: US 2003/0096764
Alpha-Hydroxyarylbutanamine Inhibitors of Aspartyl Protease
Patent: 6,696,494 →
Application: 10/007,235 →
Publication: US 2003/0207934
Nitrogen Heterocycle Inhibitors of Aspartyl Protease
Patent: 6,673,821 →
Application: 10/007,342 →
Publication: US 2003/0114500
11-O-Substituted Macrolides and Their Descladinose Derivatives
Patent: 6,673,774 →
Application: 10/011,322 →
Publication: US 2003/0114396
Novel 11-O-Substituted Ketolide Derivatives
Patent: 6,670,331 →
Application: 10/011,642 →
Publication: US 2003/0114395
5-O-Mycaminosyltylonide Derivatives
Patent: 6,710,034 →
Application: 10/125,840 →
Publication: US 2003/0203858
23-O-Substituted 5-O-Mycaminosyltylonide Derivatives
Patent: 6,753,415 →
Application: 10/126,076 →
Publication: US 2003/0212010
6-11 bicyclic erythromycin derivatives
Application: 10/144,396 →
6-11 bicyclic ketolide derivatives
Application: 10/144,558 →
11-C-Substituted Derivatives of Clarithromycin
Patent: 6,812,216 →
Application: 10/178,991 →
Publication: US 2004/0006027
11-C-Substituted Ketolides
Patent: 6,750,204 →
Application: 10/179,590 →
Publication: US 2004/0002464
6,11-4-Carbon Bridged Ketolides
Patent: 6,841,664 →
Application: 10/205,018 →
Publication: US 2004/0023895
6, 11-4-Carbon Bridged Erythromycin Derivatives
Patent: 6,753,318 →
Application: 10/205,357 →
Novel 11,12-Substituted Lactone Ketolide Derivatives Having Antibacterial Activity
Patent: 6,727,229 →
Application: 10/223,144 →
Publication: US 2004/0038915
Methods for identifying peptide aptamers capable of altering a cell phenotype
Application: 10/263,577 →
Publication: US 2003/0108532
Novel Anhydrolide Derivatives Having Antibacterial Activity
Patent: 6,720,308 →
Application: 10/289,820 →
Cyclosporins for the treatment of immune disorders
Application: 10/309,934 →
Publication: US 2004/0110666
Cyclosporin analogs for the treatment of lung diseases
Application: 10/345,855 →
Publication: US 2003/0109425
Cyclosporins for the treatment of respiratory diseases
Application: 10/345,866 →
Publication: US 2003/0109426
Cyclosporins for the Treatment of Immune Disorders
Patent: 6,979,671 →
Application: 10/349,877 →
Publication: US 2003/0166515
Cyclosporins for the Treatment of Immune Disorders
Patent: 7,012,064 →
Application: 10/349,890 →
Publication: US 2003/0186855
Cyclosporins for the Treatment of Immune Disorders
Patent: 7,012,065 →
Application: 10/360,894 →
Publication: US 2004/0157768
6,11-3C-Bicyclic 9A-Azalide Derivatives
Patent: 6,645,941 →
Application: 10/397,923 →
6-11 Bicyclic Ketolide Derivatives
Patent: 6,878,691 →
Application: 10/429,485 →
Publication: US 2005/0037982
6,11-Bicyclic Erythromycin Derivatives
Patent: 7,129,221 →
Application: 10/436,622 →
Publication: US 2004/0053861
6-O-Substituted Bicyclic Ketolides
Patent: 6,774,115 →
Application: 10/454,865 →
6-O-Substituted Bicyclic Macrolides
Patent: 6,716,820 →
Application: 10/455,001 →
Bicyclic Macrolide Derivatives
Patent: 6,790,835 →
Application: 10/455,219 →
Bicyclic Ketolide Derivatives
Patent: 6,765,016 →
Application: 10/455,648 →
6,11-4C-Bicyclic 9A-Azalide Derivatives
Patent: 6,764,998 →
Application: 10/464,188 →
Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
Application: 60/333,262 →
Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
Application: 60/357,278 →
Mu opioid receptor ligands: methods of use and synthesis
Application: 60/443,428 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 27, 2001
From: OR, YAT SUN; PHAN, LY TAM; WANG, ZHAOLIN; JIAN, TIANYING
To: ENANTA PHARMACEUTICALS, INCORPORATED
Reel/Frame 012032/0515 →
Assignment of Assignor's Interest Oct 12, 2001
From: OR, YAT SUN; LAZAROVA, TSVETELINA IVANOVA
To: ENANTA PHARMACEUTICALS, INC.
Reel/Frame 012255/0383 →
Assignment of Assignor's Interest Oct 12, 2001
From: OR, YAT SUN; LAZAROVA, TSVETELINA IVANOVA; HAMANN, BLAKE CHRISTOPHER; CHEN, JASON SHIH-HAO
To: ENANTA PHARMACEUTICALS, INC.
Reel/Frame 012256/0513 →
Assignment of Assignor's Interest Oct 22, 2001
From: OR, YAT SUN; WANG, GUOQIANG; ROUGAS, JOHN; MATHEWS, JUDE ELIZABETH
To: ENANTA PHARMACEUTICALS, INC.
Reel/Frame 012373/0327 →
Assignment of Assignor's Interest Oct 22, 2001
From: OR, YAT SUN; WANG, GUOQIANG; ROUGAS, JOHN; RIESINGER, STEVEN WAYNE
To: ENANTA PHARMACEUTICALS, INC.
Reel/Frame 012373/0719 →
Assignment of Assignor's Interest Nov 15, 2001
From: PHAN, LY TAM; BUSUYEK, MARINA V.; OR, YAT SUN
To: ENANTA PHARMACEUTICALS, INC.
Reel/Frame 012354/0802 →
Assignment of Assignor's Interest Dec 3, 2001
From: PHAN, LY TAM; NIU, DEQIANG; OR, YAT SUN
To: ENANTA PHARMACEUTICALS, INC.
Reel/Frame 012377/0232 →
Assignment of Assignor's Interest Dec 4, 2001
From: PHAN, LY TAM; NIU, DEQIANG; OR, YAT SUN
To: ENANTA PHARMACEUTICALS, INC.
Reel/Frame 012372/0545 →
Confirmatory License Apr 21, 2016
From: HARVARD UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 038489/0861 →